Work

BTK and/or PLCG2 Mutations in Patients with Chronic Lymphocytic Leukemia (CLL) Treated with Ibrutinib: Characteristics and Outcomes at the Time of Progression

Year: 2019

Type: conference-abstract

Source: Blood

DOI: 10.1182/blood-2019-125411

Authors: Paul J. Hampel, Timothy G. Call, Sara J. Achenbach, Kari G Rabe, Wei Ding, Eli Muchtar, Saad S. Kenderian, Yucai Wang, Amber Koehler, Amie Fonder, Jose F. Leis, Susan M. Schwager, Daniel L. Van Dyke, Esteban Braggio, Susan L. Slager, Neil E. Kay, Sameer A. Parikh

Institutions: Mayo Clinic, Mayo Clinic Hospital, Mayo Clinic in Arizona

Language: English

Topic: Chronic Lymphocytic Leukemia Research

Subfield: Genetics

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2983560723

Cites:

Cited by: 4

Related to: 10